secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027252
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen shareholders elect Class III directors, approve say-on-pay and auditor ratification
--------------------------------------------------------------------------------

- Enrique Conterno, Aoife Brennan, and Gerald Lema elected as Class III directors with 67.4M, 69.2M, and 67.6M votes for, respectively.
- Advisory vote on executive compensation passed: 48.7M for, 21.9M against, 89K abstain (31% opposed).
- Ratification of PricewaterhouseCoopers as auditor for 2023: 78.5M for, 674K against, 2.2M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/fgen-20230607.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer